The manufacturer of Zoton® capsules (lansoprazole) has written to healthcare professionals to announce that this product is discontinued.
Lansoprazole is available as a generic product and this had led to a decline in demand and hence the discontinuation of this product. The generic capsules remain available. The FasTab® presentation of Zoton is unaffected by this announcement and remains available.
Action: Previously, Lansoprazole has been recommended as the first-line choice when a proton pump inhibitor is indicated. This advice is unchanged however prescriptions should be generated generically. Existing patients who are prescribed the brand product should be switched to a generic alternative.
|« Vaccine administration alert||Poor compliance increases mortality »|